# Michelle Hladunewich

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michelle-hladunewich/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13,880 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 63 |
| i10-index | 152 |
| Last Known Institution | Sunnybrook Health Science Centre |
| OpenAlex ID | https://openalex.org/A5004311843 |
| ORCID iD | 0000-0001-9227-4292 |
| Works | 293 |

## Researcher papers

Showing 12 of 13.

- [Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group](https://scholariq.org/papers/oxford-classification-of-iga-nephropathy-2016-an-update-from-the-iga-nephropathy/)
- [Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy](https://scholariq.org/papers/rituximab-or-cyclosporine-in-the-treatment-of-membranous-nephropathy/)
- [Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-clinical-outcomes-in-patients-with-iga/)
- [Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach](https://scholariq.org/papers/design-of-the-nephrotic-syndrome-study-network-neptune-to-evaluate-primary/)
- [Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-decline-in-kidney-function-or-kidney/)
- [Sex-and age-based differences in the delivery and outcomes of critical care](https://scholariq.org/papers/sex-and-age-based-differences-in-the-delivery-and-outcomes-of-critical-care/)
- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)
- [Intensive Hemodialysis Associates with Improved Pregnancy Outcomes](https://scholariq.org/papers/intensive-hemodialysis-associates-with-improved-pregnancy-outcomes/)
- [Pathophysiology of the Clinical Manifestations of Preeclampsia](https://scholariq.org/papers/pathophysiology-of-the-clinical-manifestations-of-preeclampsia/)
- [Rituximab treatment of idiopathic membranous nephropathy](https://scholariq.org/papers/rituximab-treatment-of-idiopathic-membranous-nephropathy/)
- [Patients with primary membranous nephropathy are at high risk of cardiovascular events](https://scholariq.org/papers/patients-with-primary-membranous-nephropathy-are-at-high-risk-of-cardiovascular/)
- [Socioeconomic Position and Incidence of Glomerular Diseases](https://scholariq.org/papers/socioeconomic-position-and-incidence-of-glomerular-diseases/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Pregnancy and preeclampsia studies](https://scholariq.org/topics/pregnancy-and-preeclampsia-studies/)
- [Pregnancy and Medication Impact](https://scholariq.org/topics/pregnancy-and-medication-impact/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Researcher university

- [Sunnybrook Health Science Centre](https://scholariq.org/institutions/sunnybrook-health-science-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.